Monday, August 14, 2006
ARV production and government responsibilities
Anand Grover, the co-founder of the Mumbai Lawyers Collective HIV/AIDS Unit, delivered a speech on the second day of the conference titled "Human rights and Social Vulnerabilities," in which he expressed concern about the availability of inexpensive generic drugs in five to ten years with India's agreement to comply with the Agreement on Trade -Related Aspects of Intellectual Property Rights (TRIPS) regarding product patents. Lives in Focus had interviewed Grover in Mumbai earlier about this subject and asked what alternatives there are to Western pharmaceutical companies imposing licenses on Indian generic drug makers and why the Indian government itself does not begin production of the drugs. Listen to his thoughts on the subject in this podcast.